Merck Says Covid-19 Pill 'Active' Against Omicron Variant

The effectiveness of molnupiravir against Omicron has yet to be evaluated in clinical trials, said Merck, known as MSD outside the United States and Canada.

from Top World News- News18.com https://ift.tt/3g8iA6K
https://ift.tt/eA8V8J